Intuitive Surgical, Inc. (NASDAQ:ISRG - Get Free Report)'s stock price traded up 1.3% on Thursday . The company traded as high as $584.08 and last traded at $580.02. 400,239 shares traded hands during trading, a decline of 79% from the average session volume of 1,931,788 shares. The stock had previously closed at $572.71.
Wall Street Analysts Forecast Growth
A number of analysts recently commented on the stock. JPMorgan Chase & Co. upped their price target on shares of Intuitive Surgical from $575.00 to $675.00 and gave the company an "overweight" rating in a research note on Friday, January 24th. Robert W. Baird increased their target price on Intuitive Surgical from $503.00 to $565.00 and gave the stock an "outperform" rating in a research report on Thursday, October 17th. UBS Group lifted their price target on Intuitive Surgical from $500.00 to $560.00 and gave the company a "neutral" rating in a research report on Monday, January 27th. Bernstein Bank increased their price objective on Intuitive Surgical from $655.00 to $700.00 and gave the stock an "overweight" rating in a report on Monday, January 27th. Finally, Mizuho raised their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and sixteen have assigned a buy rating to the stock. Based on data from MarketBeat, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $613.10.
Check Out Our Latest Research Report on ISRG
Intuitive Surgical Trading Down 1.4 %
The stock has a market capitalization of $203.69 billion, a PE ratio of 89.22, a PEG ratio of 5.52 and a beta of 1.39. The business has a fifty day moving average price of $550.40 and a 200-day moving average price of $509.43.
Insider Buying and Selling
In other Intuitive Surgical news, CFO Jamie Samath sold 94 shares of the business's stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the completion of the sale, the chief financial officer now directly owns 2,630 shares of the company's stock, valued at $1,502,019.30. The trade was a 3.45 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at the SEC website. Also, EVP Robert Desantis sold 376 shares of the firm's stock in a transaction dated Friday, November 29th. The shares were sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares in the company, valued at $2,967,734. This trade represents a 6.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 28,843 shares of company stock worth $15,357,560 in the last quarter. 0.90% of the stock is owned by insiders.
Institutional Trading of Intuitive Surgical
Institutional investors have recently made changes to their positions in the stock. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at $26,000. Godsey & Gibb Inc. raised its stake in shares of Intuitive Surgical by 140.0% during the third quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock valued at $29,000 after acquiring an additional 35 shares during the last quarter. MidAtlantic Capital Management Inc. purchased a new stake in shares of Intuitive Surgical during the third quarter worth about $33,000. Decker Retirement Planning Inc. bought a new stake in shares of Intuitive Surgical in the fourth quarter worth about $36,000. Finally, Capital Performance Advisors LLP purchased a new position in Intuitive Surgical during the 3rd quarter valued at about $38,000. Hedge funds and other institutional investors own 83.64% of the company's stock.
About Intuitive Surgical
(
Get Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Further Reading
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's guide to investing in 5G and which 5G stocks show the most promise.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.